developing Tomorrow's innovative diagnostics

Hummingbird Diagnostics is developing liquid biopsy diagnostics for early disease detection, personalized medicine, and lifetime health monitoring based on highly disease-specific miRNA biomarkers.

mirna-based LIQUID BIOPSY DIAGNOSTICS

UPDATES ON THE LATEST DEVELOPMENTS

DX Pipeline

Explore our ground-breaking pipeline of proprietary, miRNA-based diagnostic tests from blood.

More

Newsroom

Hummingbird Diagnostics awarded by Alzheimer’s Drug Discovery Foundation (ADDF)

More

PUBLICATIONS

Learn more about genomic biomarkers and read publications from the biomarker field.

More